The incidence of malignant neoplasms in the Azerbaijan Republic

D. A Aliyev; Fuad A. Mardanli; S. S Vatankha; K. B Farkhadzadeh

doi:10.17816/onco40140

Russian Journal of Oncology ›› 2015, Vol. 20 ›› Issue (1) : 38 -41. DOI: 10.17816/onco40140

Articles

research-article

The incidence of malignant neoplasms in the Azerbaijan Republic

Author information +

History +

PDF

Abstract

Statistical analysis showed that the highest incidence of malignant tumors was observed in males at diseases of the trachea, bronchus, lung, intensive index, which was 18,9 % ooo and gastric malignancies (15,3 % ooo). Individuals female lead position taken by the disease, breast cancer and cervical cancer, intense incidence which was 31,8 % ooo and 7,0 % ooo, respectively. The greatest increase in the incidence of malignant tumors observed in both males and in females in the age group 50-59 years, which standardized ratio was 30,8 and 29,4 % ooo respectively. Revealed that the greatest cause of mortality and mortality in men were malignant neoplasms of the stomach (0.2 and 47.9% ooo respectively) and the trachea, bronchus and lung (0.1 and 51.2% ooo respectively), women - malignant neoplasm of breast (0.1 and 14.1% ooo respectively). Aggressiveness factor most likely expressed in malignant tumors of the stomach (1.3) in men and bladder (1.7), trachea, bronchus and lung (0.9) and the lips (0.8) in women.

Keywords

malignancies / extensive and intensive index / standardized index

Cite this article

Download citation ▾

D. A Aliyev, Fuad A. Mardanli, S. S Vatankha, K. B Farkhadzadeh. The incidence of malignant neoplasms in the Azerbaijan Republic. Russian Journal of Oncology, 2015, 20(1): 38-41 DOI:10.17816/onco40140

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Всемирный банк. Международный банк реконструкции и развития. Доклад о мировом развитии 2003 года: Устойчивое развитие в меняющемся мире. Преобразование институтов, рост и качество жизни. М.: Весь Мир, 2003.

[2]	WHO. National Cancer Control Programmes: Policies and Managerial Guidelines. 2nd ed. Geneva: WHO, 2002.

[3]	Parkin D.M. Global cancer statistics in the year 2000. Lancet. Oncology. 2001; 2(9): 533-43.

[4]	Parkin D.M., Whelan S.L., Ferlay J., Terro L.,Thomas D.B., eds. Cancer Incidence in Five Continents. IARC Scientific Publications. Lyon; 2002; VIII(155).

[5]	Parkin D., Bray F., Devesa S. Cancer burden in the year 2000: the global picture. Eur. J. Cancer. 2001; 37(Suppl. 8): 4-66.

[6]	Stewart B., Kleihues P., eds. World Cancer Report. Lyon; IARC Press, 2003.

[7]	WHO. Global Strategy for the Prevention and Control of Non-communicable Diseases. Reportof Director-General. EB 105/42, 16.12.1999, Geneva; 1999.

[8]	Alberti G. Noncommunicable diseases: tomorrow’s pandemic. Bull. WHO. 2001; 79(10): 906-1004.

[9]	Мерабишвили В.М. Рак молочной железы: заболеваемость, смертность, выживаемость (популяционное исследование). Вопросы онкологии. 2011; 5: 609-15.